Phenols
Aobchem 1 3 5-Tribromo-2 4-difluorobenzene | 97% | CAS 679836-62-5 | C6HBr3F2 | 500mg
1 3 5-Tribromo-2 4-difluorobenzene | 97% | CAS 679836-62-5 | C6HBr3F2 | 500mg
Aobchem 2-Bromo-3-fluoroisonicotinic acid | ≥95% | CAS 1211530-89-0 | C6H3BrFNO2 | 5g
2-Bromo-3-fluoroisonicotinic acid | ≥95% | CAS 1211530-89-0 | C6H3BrFNO2 | 5g
Aobchem 3 5-Di-tert-butylbenzoic acid | ≥97% | CAS 16225-26-6 | C15H22O2 | 25g
3 5-Di-tert-butylbenzoic acid | ≥97% | CAS 16225-26-6 | C15H22O2 | 25g
Aobchem 1-(Tert-butoxy)-2-chloro-4-iodobenzene | 95% | CAS 1369777-30-9 | C10H12ClIO | 5g
1-(Tert-butoxy)-2-chloro-4-iodobenzene | 95% | CAS 1369777-30-9 | C10H12ClIO | 5g
Aobchem 2-Iodo-4 5-dimethoxyphenyl acetate | 97% | CAS 67467-11-2 | C10H11IO4 | 250mg
2-Iodo-4 5-dimethoxyphenyl acetate | 97% | CAS 67467-11-2 | C10H11IO4 | 250mg
Medchemexpress LLC LYN-1604 hydrochloride | 2216753-86-3 | MFCD31630830 | >=98.0% | 621.08 | C33H44Cl3N3O2 | 1 MG
A small-molecule hydrochloride salt that activates UNC-51-like kinase 1 (ULK1) with a reported EC50 of 18.94 nM. It is used in vitro to study autophagy, apoptosis, and mechanisms relevant to triple-negative breast cancer. Supplied as a solid and as a 10 mM solution in DMSO; consult the certificate of analysis for lot-specific purity and storage instructions.
- Potent ULK1 activation (EC50 = 18.94 nM).
- Supports studies of autophagy and apoptosis in cancer models.
- Available as solid and as a 10 mM solution in DMSO for assay flexibility.
- Hydrochloride salt form improves solubility for biological testing.
- Certificate of analysis available for lot-specific purity and storage instructions.
Aobchem 1-(3-Bromo-5-ethoxyphenyl)-2 2-dichloroethanol | 95% | CAS 2734778-80-2 | C10H11BrCl2O2 | 1g
1-(3-Bromo-5-ethoxyphenyl)-2 2-dichloroethanol | 95% | CAS 2734778-80-2 | C10H11BrCl2O2 | 1g
Medchemexpress LLC Tecalcet hydrochloride | 177172-49-5 | MFCD16038895 | 99.7% | 340.29 g/mol | C18H23Cl2NO | 1 ML
Tecalcet hydrochloride is an orally active calcimimetic that allosterically and positively modulates the calcium-sensing receptor (CaSR). It is provided for research use in solution and solid forms and is commonly used in in vitro pharmacology and calcium-signaling studies.
- Orally active calcimimetic that modulates the calcium-sensing receptor.
- Suitable for in vitro pharmacology and CaSR signaling studies.
- Available as a 10 mM solution in DMSO (1 mL) and as solid quantities for formulation flexibility.
- High chemical purity (≈99.7%) for reliable experimental results.
- Molecular weight 340.29 g/mol and molecular formula C18H23Cl2NO.
Medchemexpress LLC Tallimustine hydroch 1mg | 118438-45-2 | 1MG
Tallimustine hydrochloride a distamycin-A derivative is an anticancer agent[1
![Medchemexpress LLC 2-((4-amino-1-(tert-butyl)-1H-pyrazolo[3,4-d]pyrimidin-3-yl)methyl)phenol | 833481-73-5 | MFCD28120704 | 99.7% | 297.35 g/mol | C16H19N5O | 1 ML](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000248416.png-250.jpg)
Medchemexpress LLC 2-((4-amino-1-(tert-butyl)-1H-pyrazolo[3,4-d]pyrimidin-3-yl)methyl)phenol | 833481-73-5 | MFCD28120704 | 99.7% | 297.35 g/mol | C16H19N5O | 1 ML
2OH-BNPP1 is a small-molecule inhibitor of BUB1 serine/threonine kinase used as a research reagent to study mitotic checkpoint signaling and cancer-related pathways. It is supplied in concentrated solution and solid formats for biochemical and cellular assays.
- Inhibits BUB1 kinase activity for cell cycle and mitosis research.
- Available as 10 mM solution in DMSO and as solid aliquots.
- High purity suitable for biochemical and cellular experiments.
- Provided with analytical and quality control data when available.
- Suitable for inhibitor profiling, cell-based assays, and mechanistic studies.
eMolecules 184163-80-2 | 4-(5-(2,6-DIMETHOXYPHENYL)-3-(METHOXYCARBONYL)-1H-PYRAZOL-1-YL)-3-ISOPROPYLBENZOIC ACID | AstaTech424.453 | C23H24N2O6 | 95.000 | COC(=O)c1cc(-c2c(OC)cccc2OC)n(n1)-c1ccc(cc1C(C)C)C(O)=O | 1g | 589772816
4-(5-(2,6-DIMETHOXYPHENYL)-3-(METHOXYCARBONYL)-1H-PYRAZOL-1-YL)-3-ISOPROPYLBENZOIC ACID | AstaTech | 184163-80-2424.453 | C23H24N2O6 | 95.000 | COC(=O)c1cc(-c2c(OC)cccc2OC)n(n1)-c1ccc(cc1C(C)C)C(O)=O | 1g | 589772816
eMolecules 22426-14-8 | 2-Bromo-1,10-phenanthroline | Ambeed | MFCD13152102 | 259.106 | C12H7BrN2 | 97.000 | Brc1ccc2ccc3cccnc3c2n1 | 10g | 525105648
2-Bromo-1,10-phenanthroline | Ambeed | 22426-14-8 | MFCD13152102 | 259.106 | C12H7BrN2 | 97.000 | Brc1ccc2ccc3cccnc3c2n1 | 10g | 525105648
Medchemexpress LLC 2-pyridinecarboxaldehyde, 6-bromo-3-fluoro | 885267-36-7 | MFCD07781224 | 99.9% | 204.00 g/mol | C6H3BrFNO | 100 G
6-Bromo-3-fluoropyridine-2-carbaldehyde is a halogenated pyridine aldehyde used as a synthetic intermediate in medicinal chemistry and organic synthesis.
- CAS number: 885267-36-7.
- Molecular formula: C6H3BrFNO.
- Molecular weight: 204.00 g/mol.
- Purity (GC): 99.92%.
- Appearance: white to light yellow solid.
- Typical pack size: 100 g.
- Storage: -20°C sealed and away from moisture; in solvent -80°C for 6 months, -20°C for 1 month.
Medchemexpress LLC Samuraciclib hydroch 1mg | 1805789-54-1 | 1MG
Samuraciclib hydrochloride (CT7001 hydrochloride) is a potent selective ATP-competitive and orally active CDK7 inhibitor with an IC50 of 41 nM Samuraciclib hydrochloride displays 45- 15- 230- and 30-fold selectivity over CDK1 CDK2 (IC50 of 578 nM) CDK5 and CDK9 respectively Samuraciclib hydrochloride inhibits the growth of breast cancer cell lines with GI50 values between 0 2-0 3 M Samuraciclib hydrochloride has anti-tumor effects[1 [2
Medchemexpress LLC Samuraciclib hydroch 10mM 1mL | 10MM 1ML
Samuraciclib (CT7001) hydrochloride hydrate is a potent selective ATP-competitive and orally active CDK7 inhibitor with an IC50 of 41 nM Samuraciclib hydrochloride hydrate displays 45- 15- 230- and 30-fold selectivity over CDK1 CDK2 (IC50 of 578 nM) CDK5 and CDK9 respectively Samuraciclib hydrochloride hydrate inhibits the growth of breast cancer cell lines with GI50 values between 0 2-0 3 M Samuraciclib hydrochloride hydrate has anti-tumor effects[1 [2